Hemophilia
Acquired Disorders
Inherited Disorders
Fibrinolysis & Regulation
Coagulation Proteins
100

This clotting factor is deficient in Hemophilia A.

Factor VIII

100

This condition present with prolonged PT & PTT, low platelet count, low fibinogen, and elevated D-dimer.

DIC

100

This disorder involves abnormal function of fibrinogen despite normal levels.

Dysfibrinogenemia

100

This substance activates plasminogen in the body.

tPA

100

This protein binds and stabilizes Factor VIII in circulation.

Willebrand factor

200

This lab result is prolonged in all types of hemophilia.

PTT

200

This condition afects both coagulation proteins and platelets due to impaired synthesis and splenic squestering. 

Liver Disease

200

This disorder results in complete absence of fibrin formation.

Afibrinogenemia

200

This enzyme breaks down fibrin clots.

Plasmin

200

This is the end product of the coagulation cascade.

Fibrin

300

This inheritance pattern explains most cases of Hemophilia A and B

X-linked recessive

300

This factor is affected earliest in Vitamin K deficiency due to shortest half-life.

Factor VII

300

This disorder produces unstable cots despite normal PT and PTT.

Factor XIII

300

This molecule is produced from the breakdown of cross-linked fibrin.

D-dimer

300

This enzyme directly converts fibrinogen into fibrin.

Thrombin

400

Hemophilia B is also called this.

Christmas Disease

400

These four factors will be decreased in Patients with vitamin K deficiency.

Factors II, VII, IX, & X

400

In this condition, protein C's ability to break down factor V is impeded, leading to hypercoagulability.

Factor V Leiden

400

Elevated levels of these indicate increased fibrin or fibrinogen breakdown.

FSPs (FDPs)

400

These two plasma proteins are synthesized by endothelial cells.

Factor VIII & vWF

500

This severity level is defined by 1-5% factor activity.

Moderate hemophilia 

500

In this condition plasmin is activated by sources other than thrombin, leading to prolonged PT and PTT, decreased fibrinogen, and increased D-dimer, while platelet count remains normal.

Primary fibrinolysis

500

This factor deficiency prolongs PTT but is not associated with clinical bleeding.

Factor XII

500

This inhibitor suppresses the function of TPA.

PAI-1 (Plasminogen activator 1)

500

This describes thrombin’s anticoagulant role.

Activation of protein C